https://orcid.org/0009-0006-9441-0247
Figures & data
Table 1 Underlying Etiology of Hepatocellular Carcinoma. Presented as Numbers and Valid Percentages
Figure 1 Inclusion flow chart.
Table 2 Patient Characteristics for Included Patients
Figure 2 Kaplan–Meier curve showing estimated lead-time adjusted survival. Non-surveillance group including only patients with a presumed surveillance indication.
Table 3 Multivariable Cox Regression Analyses for Overall Mortality, Corrected for Lead-Time Bias with a Sojourn Time of 270 Days
Figure 3 Survival curve from multivariable Cox regression analysis in patients with a follow-up time of ≥ 36 months. Non-surveillance group including only patients with a presumed surveillance indication. Adjusted for age, sex, performance status, etiology and presence of diabetes. Lead-time adjusted with a sojourn time of 270 days.
Figure 4 Comparisons between surveillance groups for meeting the UCSF-criteria, receiving curative treatment and presence of extrahepatic spread. Non-surveillance group including only those with a presumed surveillance indication.
Table 4 Estimated Median Survival Time in Months for Specific Etiology of Hepatocellular Cancer. Only Patients with Known Etiologies Included